Document is current
Any future updates will be listed below
-
Authors
Calandrini, Camilla
Schutgens, Frans
Oka, Rurika https://orcid.org/0000-0003-4107-7250
Margaritis, Thanasis
Candelli, Tito
Mathijsen, Luka
Ammerlaan, Carola
van Ineveld, Ravian L.
Derakhshan, Sepide
de Haan, Sanne
Dolman, Emmy
Lijnzaad, Philip
Custers, Lars
Begthel, Harry
Kerstens, Hindrik H. D.
Visser, Lindy L. https://orcid.org/0000-0001-7856-1981
Rookmaaker, Maarten
Verhaar, Marianne https://orcid.org/0000-0002-3276-6428
Tytgat, Godelieve A. M.
Kemmeren, Patrick https://orcid.org/0000-0003-2237-7354
de Krijger, Ronald R.
Al-Saadi, Reem https://orcid.org/0000-0002-0816-5649
Pritchard-Jones, Kathy https://orcid.org/0000-0002-2384-9475
Kool, Marcel
Rios, Anne C.
van den Heuvel-Eibrink, Marry M.
Molenaar, Jan J.
van Boxtel, Ruben https://orcid.org/0000-0003-1285-2836
Holstege, Frank C. P. https://orcid.org/0000-0002-8090-5146
Clevers, Hans https://orcid.org/0000-0002-3077-5582
Drost, Jarno
- License Information
-
More Information
Article History
Received: 10 January 2019
Accepted: 21 February 2020
First Online: 11 March 2020
Competing interests
: J.D. and H.C. are named as inventors on several patents related to leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5)+ stem cell-based organoid technology. The remaining authors declare no competing interests.
